Related references
Note: Only part of the references are listed.Post hoc analysis of a randomised, placebo-controlled, active-reference 6-week study of brexpiprazole in acute schizophrenia
Stephen R. Marder et al.
ACTA NEUROPSYCHIATRICA (2020)
The effects of illness severity, cognition, and estimated antipsychotic dopamine receptor occupancy on insight into the illness in schizophrenia: An analysis of clinical antipsychotic trials of intervention effectiveness (CATIE) data
Miracle Ozzoude et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2019)
Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
Maximilian Huhn et al.
LANCET (2019)
A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Maintenance Treatment in Adults with Schizophrenia
Andy Forbes et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)
Brexpiprazole in patients with schizophrenia: overview of short- and long-term phase 3 controlled studies
Stephen R. Marder et al.
ACTA NEUROPSYCHIATRICA (2017)
Brexpiprazole in patients with schizophrenia: overview of short- and long-term phase 3 controlled studies
Stephen R. Marder et al.
ACTA NEUROPSYCHIATRICA (2017)
Activating and Sedating Adverse Effects of Second-Generation Antipsychotics in the Treatment of Schizophrenia and Major Depressive Disorder: Absolute Risk Increase and Number Needed to Harm
Leslie Citrome
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2017)
Efficacy of brexpiprazole in patients with acute schizophrenia: Review of three randomized, double-blind, placebo-controlled studies
Christoph U. Correll et al.
SCHIZOPHRENIA RESEARCH (2016)
Efficacy and Safety of Brexpiprazole for the Treatment of Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Trial
Christoph U. Correll et al.
AMERICAN JOURNAL OF PSYCHIATRY (2015)
A multicenter, randomized, double-blind, controlled phase 3 trial of fixed-dose brexpiprazole for the treatment of adults with acute schizophrenia
John M. Kane et al.
SCHIZOPHRENIA RESEARCH (2015)
The relationship between Positive and Negative Syndrome Scale (PANSS) schizophrenia severity scores and risk for hospitalization: An analysis of the CATIE Schizophrenia Trial
Henry A. Glick et al.
SCHIZOPHRENIA RESEARCH (2015)
Initial Severity of Schizophrenia and Efficacy of Antipsychotics Participant-Level Meta-analysis of 6 Placebo-Controlled Studies
Toshi A. Furukawa et al.
JAMA PSYCHIATRY (2015)
Association of symptom severity, insight and increased pharmacologic side effects in acutely hospitalized patients with schizophrenia
Jie Zhang et al.
COMPREHENSIVE PSYCHIATRY (2014)
Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator
Kenji Maeda et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Insight into illness in late-life schizophrenia: A function of illness severity and premorbid intellectual function
Philip Gerretsen et al.
SCHIZOPHRENIA RESEARCH (2013)
Nicotine dependence and illness severity in schizophrenia
Rajeev Krishnadas et al.
BRITISH JOURNAL OF PSYCHIATRY (2012)
Symptom severity and attitudes toward medication: Impacts on adherence in outpatients with schizophrenia
Jaewon Yang et al.
SCHIZOPHRENIA RESEARCH (2012)
Previous hospital admissions and disease severity predict the use of antipsychotic combination treatment in patients with schizophrenia
Albert Bolstad et al.
BMC PSYCHIATRY (2011)
Predictors of Smoking Severity in Patients with Schizophrenia and Alcohol Use Disorders
Zsuzsa Szombathyne Meszaros et al.
AMERICAN JOURNAL ON ADDICTIONS (2011)
Factors associated with medication non-adherence in patients suffering from schizophrenia: a cross-sectional study in a universal coverage health-care system
Daniel Dassa et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2010)
Toward a Terminology for Functional Recovery in Schizophrenia: Is Functional Remission a Viable Concept?
Philip D. Harvey et al.
SCHIZOPHRENIA BULLETIN (2009)
Reliability, validity and ability to detect change of the Personal and Social Performance scale in patients with stable schizophrenia
Henry Nasrallah et al.
PSYCHIATRY RESEARCH (2008)
Social functioning as an outcome measure in schizophrenia studies
T. Burns et al.
ACTA PSYCHIATRICA SCANDINAVICA (2007)
The heterogeneity of schizophrenia in disease states
PE Mohr et al.
SCHIZOPHRENIA RESEARCH (2004)
Long-term course of schizophrenic illness: Bleuler's study reconsidered
J Modestin et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Gender differences in the relationship of homelessness to symptom severity, substance abuse, and neuroleptic noncompliance in schizophrenia
LA Opler et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2001)
Share Paper
